Voglimac Mf .2

VOGLIMAC MF 0.2 is a medication manufactured by Macleods Pharmaceuticals Ltd., primarily used in the management of type 2 diabetes mellitus. It acts as a second-line therapy when diet, exercise, and single antidiabetic agents do not achieve adequate glycemic control.

Name

• Brand Name: VOGLIMAC MF 0.2
• Common Name: Metformin and Voglibose tablets

Composition

VOGLIMAC MF 0.2 contains a combination of two active ingredients:

• Metformin (500 mg)
• Voglibose (0.2 mg)

Uses

VOGLIMAC MF 0.2 is prescribed for:

• Improving control of blood sugar levels in adults with type 2 diabetes mellitus.
• Managing high blood sugar levels that occur after meals (postprandial hyperglycemia).
• As an adjunct to diet and exercise, particularly when these alone or combined with other diabetes medicines are insufficient.
• Enhancing insulin sensitivity and reducing glucose production by the liver.

Dosage and Administration

VOGLIMAC MF 0.2 should be taken orally as directed by a physician.

• It is generally recommended to take the tablet with or after meals to minimize gastrointestinal discomfort.
• Swallow the tablet whole with a glass of water; do not crush, chew, or break it.
• The exact dose and duration will be determined by the doctor based on the patient's age, body weight, and medical condition.
• Do not discontinue the medication without consulting a doctor.

Side Effects

Common Side Effects:

• Nausea, vomiting
• Diarrhea, stomach pain, abdominal discomfort, flatulence
• Headache, dizziness
• Loss of appetite, changes in taste

Serious Side Effects (Rare):

• Lactic acidosis (symptoms include vomiting, stomach pain, decreased heartbeat, difficulty breathing, muscle cramps, severe tiredness, or reduced body temperature)
• Hypoglycemia (low blood sugar), especially when taken with other antidiabetic medications or alcohol. Symptoms may include excessive hunger, shaking, sweating, confusion, anxiety, and fast heartbeat.
• Hepatitis (inflammation of the liver with symptoms like tiredness, loss of appetite, weight loss, with or without yellowing of skin or eyes).

Precautions

• Allergies: Do not take if allergic to metformin, voglibose, or any other components of the tablet.
• Contraindications: Not recommended for individuals with severe kidney or liver problems, acute metabolic acidosis (including diabetic ketoacidosis), severe renal failure, alcoholism, diabetic pre-coma, or gastrointestinal obstruction.
• Pregnancy and Breastfeeding: Generally not recommended for use in pregnant or breastfeeding women due to lack of safety data.
• Alcohol Consumption: Avoid alcohol as it can increase the risk of lactic acidosis.
• Elderly Patients: Use with caution in patients aged 65 years or above, with frequent monitoring of kidney function.
• Children: Not recommended for use in children under 18 years due to lack of established safety and effectiveness.
• Drug Interactions: Inform your doctor about all other medicines, supplements, or herbal preparations being taken, as VOGLIMAC MF 0.2 may interact with other antidiabetic medications, diuretics, corticosteroids, and certain heart or blood pressure medications. Long-term use may reduce vitamin B12 absorption.
• Driving and Machinery: May cause hypoglycemia, which can affect the ability to drive or operate machinery. Patients should be aware of hypoglycemia symptoms.

Storage

• Keep VOGLIMAC MF 0.2 out of reach of children.
• Store at room temperature, ideally below 25°C or 30°C.
• Protect from moisture and light.

VOGLIMAC MF 0.2 is a medication primarily used for the management of type 2 diabetes mellitus. It is a combination of two active ingredients: Metformin and Voglibose.

What is VOGLIMAC MF 0.2 used for?

VOGLIMAC MF 0.2 is indicated as a second-line therapy for adults with type 2 diabetes mellitus when diet, exercise, and therapy with single agents do not result in adequate glycemic control. It helps to improve overall blood sugar control, including high blood sugar levels after meals.

How does VOGLIMAC MF 0.2 work?

This medicine combines the actions of two anti-diabetic drugs:

• Metformin: It reduces glucose production in the liver, decreases the absorption of glucose from the intestines, and enhances the body's sensitivity to insulin, allowing it to use sugar more effectively.
• Voglibose: It belongs to the class of alpha-glucosidase inhibitors. It works by slowing down the breakdown and absorption of complex carbohydrates in the gut, thereby preventing a sudden rise in blood sugar levels immediately after meals.

What is the usual dosage?

VOGLIMAC MF 0.2 should be taken as directed by your physician. It is generally advised to take this medicine with or after meals to help reduce gastrointestinal discomfort. The tablet should be swallowed whole with a glass of water and not crushed or chewed. Your doctor will determine the correct dose and duration based on your age, body weight, and disease condition.

What are the possible side effects?

Common side effects of VOGLIMAC MF 0.2 include nausea, vomiting, diarrhea, stomach pain or discomfort, flatulence (gas), changes in taste, headache, and dizziness.

More serious, but rare, side effects can include:

• Lactic Acidosis: Symptoms may include vomiting, stomach pain, decreased heartbeat, difficulty breathing, muscle cramps, general weakness with severe tiredness, or reduced body temperature.
• Hypoglycemia (low blood sugar): This can occur, especially if taken with other antidiabetic drugs, alcohol, or if meals are missed. Symptoms include excessive hunger, headache, shaking, sweating, confusion, anxiety, or a fast heartbeat. If you experience any severe or persistent side effects, contact your doctor immediately.

Is it safe during pregnancy or breastfeeding?

VOGLIMAC MF 0.2 is generally not recommended for use in pregnant women unless considered absolutely necessary by a physician, due to a lack of safety and effectiveness data and potential harmful effects on the developing baby.

For breastfeeding women, VOGLIMAC MF 0.2 is also generally not recommended. Metformin, one of its components, is known to pass into breast milk, and its impact on the nursing infant is a concern. Your doctor will weigh the benefits and potential risks.

Can it be taken with other medications?

VOGLIMAC MF 0.2 may interact with other medicines. It is important to inform your doctor about all medicines, supplements, or herbal preparations you are currently taking. Some potential interactions include:

• Cationic medicines like amiloride, digoxin, and morphine.
• Medicines that can increase the risk of lactic acidosis, such as topiramate and ranolazine.
• Certain anti-inflammatory drugs (e.g., prednisolone, phenylbutazone), diuretics (e.g., furosemide, metolazone), and some heart or blood pressure medications (e.g., propranolol).
• It can also decrease the absorption of Vitamin B12 and folic acid, requiring monitoring.

What precautions should be taken?

• Alcohol: Avoid consuming alcohol while taking VOGLIMAC MF 0.2, as it can increase the risk of lactic acidosis and may cause dizziness or sleepiness.
• Kidney and Liver Conditions: VOGLIMAC MF 0.2 is contraindicated in patients with severe kidney or liver problems due to an increased risk of serious side effects like lactic acidosis. Your doctor may perform blood tests to check your kidney function before and during treatment.
• Other Conditions: Inform your doctor if you have acute metabolic acidosis, severe infections, heart disease, or are undergoing surgery.
• Driving: While VOGLIMAC MF 0.2 generally does not affect driving ability, it may cause hypoglycemia (low blood sugar), which can impair concentration and vision. If you experience symptoms of low blood sugar, avoid driving or operating machinery.
• Diet and Exercise: This medication works best when combined with a healthy diet and regular exercise as advised by your healthcare provider.

What happens if a dose is missed?

If you miss a dose of VOGLIMAC MF 0.2, take it as soon as you remember with food. However, if it is almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not double the dose to catch up.

How should it be stored?

Keep VOGLIMAC MF 0.2 out of reach of children. Store it at room temperature (typically below 30°C or 25°C), protected from moisture and direct sunlight.